Varian has completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumours. According to a press release, this acquisition expands the portfolio of Varian interventional oncology solutions. Back in July, Varian revealed it had signed an asset purchase agreement to [...]